expected to reach USD 1.72 billion by 2028 registering a CAGR of 15.02%, according to a new report by Grand View Research, Inc. Key drivers contributing to market expansion include the growing adoption of sequencing platforms for clinical diagnosis because of a significant reduction in the cost of installation. The easy availability of genomic and proteomic data is also expected to create lucrative growth opportunities in this market during the forecast period. Key suggestions from the report: Services dominated the products segment in 2020 and will retain the leading position growing at the fastest CAGR during the forecast period Although NGS is advantageous in terms of affordability and speed, many research entities are unable to adopt it owing to a lack of sufficient computational infrastructure and skilled professionals to analyze the generated information